Signifor LAR (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Signifor LAR drug offered from Novartis Pharmaceuticals Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | pasireotide |
| SUBSTANCE NAME: | |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-12-15 |
| END MARKETING DATE: | 0000-00-00 |
Signifor LAR HUMAN PRESCRIPTION DRUG Details:
| Item Description | Signifor LAR from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2014-12-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0641_ee1e0de3-3f24-4d65-937a-2955a90ea9ab |
| PRODUCT NDC: | 0078-0641 |
| APPLICATION NUMBER: | NDA203255 |